ARTICLE | Clinical News
TMC114 regulatory update
January 16, 2006 8:00 AM UTC
JNJ's subsidiary Tibotec Pharmaceuticals Ltd. (Cork, Ireland) submitted an MAA to EMEA for TMC114 to treat HIV infection. An NDA for the second-generation protease inhibitor (PI) was submitted last mo...